FAculty directory

Back to alphabetical index

Gaddamanugu L. Prasad, PhD

Associate Professor, Physiology

Telephone:  215-707-3460

Fax:  215-707-5737

Email: gaddamanugu.prasad@temple.edu

Department of Physiology

Medical degree, Indian Institute of Science, Bangalore, India, 1985

 

Internship, Indian Institute of Science, 1984-1986

 

Visiting Fellow, NCI, NIH Bethesda, Maryland, Laboratory of Dr. Herbert L Cooper, 1987-1990

 

Visiting Associate, NCI, NIH Bethseda, Maryland, Laboratory of Dr. Herbert L Cooper, 1990-1992

 

Return to top

• Cytoskeletal proteins in malignant transformation of cells

• Mechanisms of tumor cell survival

• Nanotechnology solutions for development of anticancer drugs and detection of cancer cells
  

Return to top

Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

17243738. Pathak P, Prasad GL, Meziani MJ, Joudeh AA, Sun YP, Nanosized paclitaxel particles from supercritical carbon dioxide processing and their biological evaluation. Langmuir 23:5(2674-9)2007 Feb 27

17169152. Levi N, Hantgan RR, Lively MO, Carroll DL, Prasad GL, C60-fullerenes: detection of intracellular photoluminescence and lack of cytotoxic effects. J Nanobiotechnology 4:(14)2006 Dec 14

17059469. Kahner BN, Shankar H, Murugappan S, Prasad GL, Kunapuli SP, Nucleotide receptor signaling in platelets. J Thromb Haemost 4:11(2317-26)2006 Nov

16757342. Prasad GL, Regulation of the expression of tropomyosins and actin cytoskeleton by ras transformation. Methods Enzymol 407:(410-22)2006

16170368. Bharadwaj S, Thanawala R, Bon G, Falcioni R, Prasad GL, Resensitization of breast cancer cells to anoikis by tropomyosin-1: role of Rho kinase-dependent cytoskeleton and adhesion. Oncogene 24:56(8291-303)2005 Dec 15

16122869. Bharadwaj S, Shah V, Tariq F, Damartoski B, Prasad GL, Amino terminal, but not the carboxy terminal, sequences of tropomyosin-1 are essential for the induction of stress fiber assembly in neoplastic cells. Cancer Lett 229:2(253-60)2005 Nov 18

14722123. Bharadwaj S, Hitchcock-DeGregori S, Thorburn A, Prasad GL, N terminus is essential for tropomyosin functions: N-terminal modification disrupts stress fiber organization and abolishes anti-oncogenic effects of tropomyosin-1. J Biol Chem 279:14(14039-48)2004 Apr 2

13679858. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL, Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 22:40(6194-203)2003 Sep 18

12213212. Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, Salomon D, Prasad GL, Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res 279:1(40-51)2002 Sep 10

12065096. Bharadwaj S, Prasad GL, Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. Cancer Lett 183:2(205-13)2002 Sep 26

11360195. Shah V, Bharadwaj S, Kaibuchi K, Prasad GL, Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway. Oncogene 20:17(2112-21)2001 Apr 19

10696235. Shah V, Braverman R, Prasad GL, Suppression of neoplastic transformation and regulation of cytoskeleton by tropomyosins. Somat Cell Mol Genet 24:5(273-80)1998 Sep

10208425. Prasad GL, Masuelli L, Raj MH, Harindranath N, Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene 18:11(2027-31)1999 Mar 18

9253511. Prasad GL, Lee HS, Iwahashi M, Milenic DE, Abrams S, Schlom J, Kashmiri SV, In vivo gene inoculation of a recombinant single-chain antitumor antibody induces anti-immunoglobulin response. Cancer Gene Ther 4:4(253-9)1997 Jul-Aug

8760295. Braverman RH, Cooper HL, Lee HS, Prasad GL, Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene 13:3(537-45)1996 Aug 1

8076628. Prasad GL, Fuldner RA, Braverman R, McDuffie E, Cooper HL, Expression, cytoskeletal utilization and dimer formation of tropomyosin derived from retroviral-mediated cDNA transfer. Metabolism of tropomyosin from transduced cDNA. Eur J Biochem 224:1(1-10)1994 Aug 15

8346214. Prasad GL, Fuldner RA, Cooper HL, Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci U S A 90:15(7039-43)1993 Aug 1

1390337. Prasad GL, Valverius EM, McDuffie E, Cooper HL, Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells. Cell Growth Differ 3:8(507-13)1992 Aug

2059197. Prasad GL, Meissner S, Sheer DG, Cooper HL, A cDNA encoding a muscle-type tropomyosin cloned from a human epithelial cell line: identity with human fibroblast tropomyosin TM1. Biochem Biophys Res Commun 177:3(1068-75)1991 Jun 28

2317800. Bhattacharya B, Prasad GL, Valverius EM, Salomon DS, Cooper HL, Tropomyosins of human mammary epithelial cells: consistent defects of expression in mammary carcinoma cell lines. Cancer Res 50:7(2105-12)1990 Apr 1

Return to top

• Epithelial Cell Specific Differentiation Marker, US Patent Numbers 5,424,191 and 5,776,676

• Tropomyosin antibodies (licensed) to a leading company

• Fullerene-doxorubicin conjugates for cancer chemotherapy (invention disclosure filed)
     

Return to top